pharma · Myotonic Dystrophy type 1 and type 2 (DM1/DM2) · Non-Dystrophic Myotonias (NDM)
Lupin (Europe)
Lupin Europe GmbH
News and analysis for Lupin (Europe) on NovaPharmaNews — regulatory, clinical, and market coverage.
EU HQ
37 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- EU
- Employees
- 37
- Programs
- 4
- Drugs
- 9
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning Lupin (Europe) — regulatory, clinical, and market coverage.
News and analysis for Lupin (Europe) on NovaPharmaNews — regulatory, clinical, and market coverage.